OrbusNeich stent generates promising six-month data; Natus Medical revenue soars;

 @FierceMedDev:  Shoe-mounted lever could power artificial heart pumps. More | Follow @FierceMedDev

 @MarkHFierce: Check out FierceDrugDelivery's latest - a great look at some advances in nanotech drug delivery. Special report | Follow @MarkHFierce

 @DamianFierce:  PRA is lining up to go public, filing a confidential draft with the SEC. Article | Follow @DamianFierce

> OrbusNeich says its Genous Stent generated a much lower rate of binary restenosis versus bare metal stents after six months, in patients with low-risk acute coronary syndrome. Release

> Syntermed gained the FDA's 510(k) clearance for its new Emory cardiac Toolbox 4.0, which creates a game changing environment for nuclear cardiac labs. Item

> Galt Medical's layoffs in Texas will eliminate 139 jobs. Story

> Natus Medical ($BABY) produced nearly $86 million in revenue during its fiscal 2013 first quarter, up from $59.4 million the year before. And net income hit $3.4 million, versus just $289,000 over the same period in 2012. Release

> Welch Allyn plans to showcase a new blood pressure cuff and other technology at the National Teaching Institute & Critical Care Exposition this week in Boston. Release

> Researchers at the University of Limerick developed a new metal for medical devices such as stents that could help make them more visible inside the body under an x-ray. Item

> Life Technologies ($LIFE) gained approval to use a line of genetic analyzers in Mexico for diagnostics. Item

Biotech News

 @FierceBiotech:  Life sciences VC firm launches 'crowdfunding' site for limited crowd. More | Follow @FierceBiotech

 @JohnCFierce: Pentagon advisor pocketed biotech's cash while promoting its interests - via LATimes. Report | Follow @JohnCFierce

 @RyanMFierce: Interesting 'Open Research Exchange' platform debuts for creating outcome measures from the crowd. Release | Follow @RyanMFierce

> Elan orchestrates $693M biotech buyout, $90M spinout in deal frenzy. Report

> Effector Therapeutics snags $45M venture round from A-list backers. News

Pharma News

 @FiercePharma: Biopharma's 20 highest-paid CEOs. Our latest special report on exec pay. Report | Follow @FiercePharma

 @EricPFierce: AstraZeneca rides Crestor to top of cardio drug list. Special report | Follow @EricPFierce

> Women want Apotex to pay for unwanted pregnancies. Article

> Actavis nabs Warner Chilcott in a $8.5B stock swap. News

> JVs like Pfizer, Hisun hookup provide Chinese companies shot at Western markets. Report

CRO News

> Nordion inks CMO deal with Navidea. Report

> After successful IPO, Quintiles plots 400 job cuts. Item

> PRA winds up for IPO. News

> Quintiles signs on to help Merck KGaA right the R&D ship. More

> PPD's BioDuro opens Shanghai discovery lab. Story

>WuXi's revenue jumps 11.7% in strong Q1. Article

Biotech IT News

> Drugmaker UCB taps IBM for digital medicine effort. Article

> InSilico Genomics grabs $1.5M for fledgling bioinformatics biz. Report

> Life sciences VC firm launches 'crowdfunding' site for limited crowd. Article

> Sanofi hunts for clinical trial recruits in growing social network. Story

> Merck targets docs with revamped U.K. website and healthcare apps. News

Suggested Articles

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,